CNS – Psychiatry

A Japan-based, global pharmaceutical development company leveraged Signant’s eCOA solutions and expertise to ensure endpoint reliability for their phase 3...

Signant Health offers unparalleled scientific and clinical expertise along with schizophrenia trialexperience and a proven track record for international delivery...

In our April 12 webinar, Ratings Methods to Assure Clinical Precision in CNS Trials, our renowned experts shared key considerations...

Signant Health’s Central Rating services played an important role in five clinical trials for major depressive disorder (MDD) by helping to...

Watch our video to learn how our digital solutions and clinical science expertise can support the development of new schizophrenia...

A pharmaceutical company needed to ensure proper dispensation of their investigational product (IP) around variable visit schedules across multiple patient...

Take advantage of Signant SmartSignals – a suite of comprehensive clinical research solutions – to optimize generalized anxiety disorder (GAD)...

As the evidence generation company, Signant advises study teams on navigating unique challenges. Our SmartSignals solutions can simplify attention-deficit/hyperactivity disorder...

Signant’s comprehensive clinical research solutions and scientific expertise in psychiatric disorders helps attention-deficit hyperactivity studies succeed by improving endpoint data...

Can a blood test predict treatment response to antidepressants? Recent research conducted by Signant’s scientific director, Steven Targum, M.D., along...